3.8 Article

Adult-onset carnitine palmitoyl transferase II (CPT II) deficiency presenting with rhabdomyolysis and acute kidney injury

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, Research & Experimental

Whole-exome sequencing detects PYGM variants in two adults with McArdle disease

Amanda Thomas-Wilson et al.

Summary: McArdle disease is a glycogen storage disease typically onset in childhood. In this case report, a former competitive athlete and a septuagenarian with exercise intolerance since adolescence were both found to have biallelic variants in the PYGM gene. The former athlete had a common pathogenic variant in trans with a novel missense variant, while the second individual had a previously described homozygous missense variant.

COLD SPRING HARBOR MOLECULAR CASE STUDIES (2022)

Article Genetics & Heredity

Outcomes of mitochondrial long chain fatty acid oxidation and carnitine defects from a single center metabolic genetics clinic

Anastasia Ambrose et al.

Summary: This study reports on the phenotypic and genotypic spectrum of mitochondrial long-chain fatty acid oxidation and carnitine metabolism defects, comparing treatment outcomes between symptomatic and asymptomatic patients. The study identified seven different defects and found that symptomatic patients had higher hospital admission rates and longer hospital stays.

ORPHANET JOURNAL OF RARE DISEASES (2022)

Article Genetics & Heredity

Detection of Early Onset Carnitine Palmitoyltransferase II Deficiency by Newborn Screening: Should CPT II Deficiency Be a Primary Disease Target?

Rachel Mador-House et al.

Summary: Early-onset CPT II deficiency is a severe condition that requires early detection and intervention, which can lead to better clinical outcomes. Newborn screening for CPT II deficiency is highly sensitive and specific, making it an effective tool for early diagnosis and treatment.

INTERNATIONAL JOURNAL OF NEONATAL SCREENING (2021)

Review Biochemistry & Molecular Biology

Muscle Carnitine Palmitoyltransferase II (CPT II) Deficiency: A Conceptual Approach

Pushpa Raj Joshi et al.

MOLECULES (2020)

Review Biology

Update Review about Metabolic Myopathies

Josef Finsterer

LIFE-BASEL (2020)

Review Clinical Neurology

Metabolic lipid muscle disorders: biomarkers and treatment

Corrado Angelini et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2019)

Article Endocrinology & Metabolism

Fluxomic assay-assisted diagnosis orientation in a cohort of 11 patients with myopathic form of CPT2 deficiency

Monique Fontaine et al.

MOLECULAR GENETICS AND METABOLISM (2018)

Review Cell Biology

The carnitine system and cancer metabolic plasticity

Mariarosa Anna Beatrice Melone et al.

CELL DEATH & DISEASE (2018)

Article Urology & Nephrology

McArdle disease: a pediatric disorder presenting in an adult with acute kidney injury

Xixi Zhao et al.

CEN CASE REPORTS (2017)

Review Clinical Neurology

Update on diagnostics of metabolic myopathies

Antonio Toscano et al.

CURRENT OPINION IN NEUROLOGY (2017)

Review Clinical Neurology

Diagnostic evaluation of rhabdomyolysis

Jessica R. Nance et al.

MUSCLE & NERVE (2015)

Review Clinical Neurology

A Diagnostic Algorithm for Metabolic Myopathies

Andres Berardo et al.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2010)

Article Endocrinology & Metabolism

A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation

Sander Michel Houten et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2010)

Article Genetics & Heredity

Disorders of carnitine transport and the carnitine cycle

N Longo et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2006)

Article Pediatrics

Long-chain fatty acid oxidation during early human development

NA Oey et al.

PEDIATRIC RESEARCH (2005)